Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Current Assets:
Cash and equivalents	$ 711	$ 1,717
Restricted cash	102	139
Short-term investments	17	445
Trade receivables, net	2,638	3,033
Inventories:
Materials	904	803
Work in process	453	443
Finished products	2,502	2,597
Inventories	3,860	3,843
Prepaid expenses and other	1,331	1,292
Total Current Assets	8,659	10,468
Property, Plant and Equipment	14,156	14,378
Less allowances for depreciation and amortization	7,554	7,557
Property, Plant and Equipment, Net	6,602	6,821
Goodwill	26,329	26,465
Developed Technology, Net	7,439	7,733
Customer Relationships, Net	2,533	2,635
Other Intangibles, Net	517	549
Other Assets	2,586	2,615
Total Assets	54,665	57,286
Current Liabilities:
Current debt obligations	1,318	2,170
Payables, accrued expenses and other current liabilities	6,347	6,786
Total Current Liabilities	7,664	8,956
Long-Term Debt	17,440	17,940
Long-Term Employee Benefit Obligations	939	942
Deferred Income Taxes and Other Liabilities	3,418	3,558
Commitments and Contingencies (See Note 5)
Shareholders’ Equity
Common stock — $1 par value; authorized — 640,000,000 shares; issued — 370,594,401 shares in December 31, 2024 and September 30, 2024	371	371
Capital in excess of par value	19,768	19,893
Retained earnings	16,141	16,139
Deferred compensation	25	25
Treasury stock	(9,425)	(8,807)
Accumulated other comprehensive loss	(1,676)	(1,732)
Total Shareholders’ Equity	25,205	25,890
Total Liabilities and Shareholders’ Equity	$ 54,665	$ 57,286